Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
valuation ratios | |
---|---|
pe ratio | 95.14 |
peg ratio | 22.04 |
price to book ratio | -25.23 |
price to sales ratio | 2.35 |
enterprise value multiple | 27.53 |
price fair value | -25.23 |
profitability ratios | |
---|---|
gross profit margin | 89.43% |
operating profit margin | 6.03% |
pretax profit margin | 2.46% |
net profit margin | 2.46% |
return on assets | 2.78% |
return on equity | -14.8% |
return on capital employed | 11.17% |
liquidity ratio | |
---|---|
current ratio | 1.96 |
quick ratio | 1.87 |
cash ratio | 0.95 |
efficiency ratio | |
---|---|
days of inventory outstanding | 104.89 |
operating cycle | 175.76 |
days of payables outstanding | 83.64 |
cash conversion cycle | 92.11 |
receivables turnover | 5.15 |
payables turnover | 4.36 |
inventory turnover | 3.48 |
debt and solvency ratios | |
---|---|
debt ratio | 0.43 |
debt equity ratio | -4.12 |
long term debt to capitalization | 1.32 |
total debt to capitalization | 1.32 |
interest coverage | 1.21 |
cash flow to debt ratio | 0.18 |
cash flow ratios | |
---|---|
free cash flow per share | 0.60 |
cash per share | 3.47 |
operating cash flow per share | 0.61 |
free cash flow operating cash flow ratio | 0.99 |
cash flow coverage ratios | 0.18 |
short term coverage ratios | 0.00 |
capital expenditure coverage ratio | 89.40 |
Frequently Asked Questions
Rigel Pharmaceuticals, Inc. (RIGL) published its most recent earnings results on 07-11-2024.
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL)'s trailing twelve months ROE is -14.8%.
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Rigel Pharmaceuticals, Inc. (RIGL) currently has a ROA of 2.78%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
RIGL reported a profit margin of 2.46% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
Apple's current ratio, which measures its ability to pay short-term obligations, was 1.96 in the most recent quarter. The quick ratio stood at 1.87, with a Debt/Eq ratio of -4.12.